Antiphospholipid syndrome treatment beyond anticoagulation: are we there yet?
about
Progression of antiphospholipid antibody syndrome to catastrophic antiphospholipid antibody syndrome acutely with cessation of antithrombotic therapy.Inhibition of nitric oxide and antiphospholipid antibody-mediated thrombosis.Right Atrial Thrombosis in Antiphospholipid Syndrome with Secondary Immune Thrombocytopenia.Nonarteritic anterior ischemic optic neuropathy as the presenting manifestation of primary antiphospholipid syndrome.New therapeutic targets for the antiphospholipid syndrome.Treatment of Thrombotic Antiphospholipid Syndrome: The Rationale of Current Management-An Insight into Future Approaches.Anticoagulation in management of antiphospholipid antibody syndrome in pregnancy.Hydroxychloroquine use is associated with lower odds of persistently positive antiphospholipid antibodies and/or lupus anticoagulant in systemic lupus erythematosusManagement of obstetric antiphospholipid syndrome.The management of stroke in antiphospholipid syndrome.New Insights into the Molecular Basis of the Antiphospholipid Syndrome.Top 10 clinical research developments in antiphospholipid syndrome.Management of recurrent thrombosis in antiphospholipid syndrome.Current status and future prospects for the treatment of antiphospholipid syndrome.Immunotherapeutic strategies in antiphospholipid syndrome.Antiphospholipid syndrome and recurrent thrombosis--limitations of current treatment strategies.Complement C5-inhibitor rEV576 (coversin) ameliorates in-vivo effects of antiphospholipid antibodies.
P2860
Q33401365-4C1BBF01-0029-4A87-AB7C-9340DF6E88EDQ33406588-D0417190-6E3B-468C-BF85-4240407CD813Q33428599-C0DC9A42-D5B2-43E0-A20F-FD722A1588E1Q33786059-BCC226CF-262E-47FF-A3DB-03B1D95720F6Q34140319-22A59DA4-AE06-4EFB-9E71-A60CBE68D696Q35621012-010363C1-B2BF-41FC-AE47-3E7F7B446EA1Q36879113-3CAF7EC0-4F62-43A0-8D43-7CD0DD071E3DQ37158591-B2142294-8734-4617-B5E1-18E2A07A74F3Q37959314-573E0478-FC2C-4B09-8E0B-C28E71EF6DBCQ37959884-42FE0810-B391-41C3-BC02-55D8BDCBEBABQ38024789-69218F9B-8EC4-4FC5-A678-36F613C3B688Q38135335-B1EFB2D9-2FBA-4E98-95D6-9519E85DD1D1Q38180647-C3E6B1D1-02AA-4761-9208-831166429BB6Q38818425-381D8093-EAA2-4D20-A8BC-75E78AFE8CC6Q38826804-3B7B0B46-719C-4F6C-93EC-13162CC7FA7DQ41838557-0DCDECA8-596E-40F1-9FD2-1BCD822D207CQ43984230-1C0B495D-F47C-483C-A19D-722FF63F0B4F
P2860
Antiphospholipid syndrome treatment beyond anticoagulation: are we there yet?
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on April 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Antiphospholipid syndrome treatment beyond anticoagulation: are we there yet?
@en
Antiphospholipid syndrome treatment beyond anticoagulation: are we there yet?
@nl
type
label
Antiphospholipid syndrome treatment beyond anticoagulation: are we there yet?
@en
Antiphospholipid syndrome treatment beyond anticoagulation: are we there yet?
@nl
prefLabel
Antiphospholipid syndrome treatment beyond anticoagulation: are we there yet?
@en
Antiphospholipid syndrome treatment beyond anticoagulation: are we there yet?
@nl
P2860
P356
P1433
P1476
Antiphospholipid syndrome treatment beyond anticoagulation: are we there yet?
@en
P2093
S S Pierangeli
P2860
P304
P356
10.1177/0961203310361489
P577
2010-04-01T00:00:00Z